Lv4
460 积分 2024-12-02 加入
P2.06.100 Initial Biomarker Results From the Phase 2A Study of AFM24 With Atezolizumab in Patients With Advanced/Metastatic NSCLC
2小时前
求助中
Report of the 2003 Pan-Canadian Forum on Cervical Cancer Prevention and Control
2小时前
已完结
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer
9天前
已完结
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
4个月前
已关闭
Recent advances in therapeutic cancer vaccines
4个月前
已完结
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
5个月前
已完结
Cancer vaccines: the next immunotherapy frontier
10个月前
已完结
Combined KRAS inhibition and immune therapy generates durable complete responses in an autochthonous PDAC model
11个月前
已完结
皖公网安备34019202002308
